Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.30−0.08 (-3.36%)
Close on Nov 13, 2026Market cap $109.82MP/E –Yield –
Minerva Neurosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Minerva Neurosciences's profit margin for the twelve months ending Mar 31, 2021 was 12.8%. For fiscal 2020 it was 4.7%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | 4.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | 71.7% | – |
See a number that looks wrong?